Injective (INJ) is currently trading at $3.00, showing a 24-hour decline of approximately 3.89%. The price has fluctuated between a daily high of $3.12 and a low of $2.95, indicating a modest volatility range of 0.17%.

The trading volume over the past 24 hours stands at 46,390,804, which corresponds to a volume-to-market cap ratio of 15.44%. This level of volume suggests moderate market activity but may not be sufficient to drive significant price changes given the recent downward trend.

The hourly moving averages indicate a bearish sentiment, with the 8 SMA at $3.03 (-1.10%) and the 21 SMA also trending lower at $3.03 (-1.12%). Additionally, the 144 SMA at $3.14 reflects a more substantial decrease of 4.37%, supporting the notion that short-term momentum is bearish.

The 1-hour RSI is currently at 44, indicating a neutral position but leaning towards oversold conditions, while the 7-day RSI at 47 suggests a similar stance with potential for further declines. The price has seen significant drops over longer periods, with a 7-day change of -12.30%, a 14-day change of -4.72%, and a 30-day change of -24.19%, showcasing consistent bearish pressure.

Given the data, Injective remains far below its all-time high of $52.62 achieved on March 14, 2024, indicating substantial market retracement. The combination of declining prices, bearish moving averages, and lower RSI levels points to ongoing selling pressure.

In conclusion, the analysis suggests a Sell rating for Injective (INJ) based on the current bearish market sentiment and technical indicators. The persistent decline in price over various time frames indicates that further downside risk remains, warranting caution for potential investors.